Treatments for Rare Diseases
Currently, a significant proportion of the pharmaceutical development pipeline is represented by drugs used to treat rare diseases and, increasingly, gene therapies. For example, 44 drugs in ClearScript’s Brand Pipeline Forecast are used to treat rare diseases and are up for approval in the upcoming six months.
ClearScript continues to monitor the pharmaceutical pipeline to keep you apprised of drugs that may impact your benefit costs. Contact us to learn how we manage spend for these and other drugs while still providing exceptional service to your members.